Results: Synovitis was found in MTP joints in 41 (14.6%) of 280 toes. The incidence rates of synovitis in the deformity group, the bone erosion group, and the normal group were 27.3%, 13.1%, and 6.7%, respectively. Synovitis was found in 21.7% of patients on therapy with biologic products and in 38.3% of those without such therapy. There were no significant differences in the mean duration of the disease, visual analogue scale score, erythrocyte sedimentation rate, matrix metallopeptidase 3 level, or health assessment questionnaire score among the 3 groups. Conclusions: Synovitis was also found in patients who showed no changes on imaging of the toes. Synovitis persisted in some patients even after establishment of toe deformity. Drug therapy, intensification of conservative therapy, and synovectomy should be considered to prevent further deformation. 1 . A novel bone tracer, Technetium-3,3-diphosphono-1,2-propanodicarboxylic acid (99m) (Tc-DPD) largely abrogates the need for cardiac biopsy, identifying cardiac ATTR amyloidosis with a sensitivity of 98% and specificity of 70% 2 . Amyloid deposition can be readily identified by Congo red staining of carpal tunnel biopsies taken at routine decompression surgery. Immunohistochemistry (IHC) is usually able to determine the amyloid fibril protein (amyloid type). Rheumatologists are ideally placed to request CT biopsy. Developing this underused but diagnostic test is of particular importance in light of emerging therapies for ATTR amyloidosis. Objectives: To determine the utility of CT biopsy as a diagnostic tool in systemic ATTR amyloidosis, and its utility in combination with Tc-DPD scintigraphy in identifying pre-clinical cardiac amyloidosis. Methods: CT biopsies were taken at decompression surgery. Biopsies were stained with Congo red and viewed under cross polarised light. IHC was used to type amyloid deposits using standardised techniques. Results: We analysed 37 CT biopsies, 73% female, median age 65.8 yrs (35-87 yrs). 5 biopsies contained amyloid deposits (13.5%) by Congo red staining. 3 were typed as ATTR amyloid using immunohistochemistry (8%), median age 80.35 yrs. The amyloid type could not be determined by IHC in two cases. No cases of proven ATTR amyloid had a history of heart failure symptoms. Of these, a 74 yr old male attended the NAC for diagnostic work up. He had a normal ECG and Echocardiogram, however, Tc-DPD scintigraphy was able to demonstrate low grade uptake. Conclusions: Carpal tunnel biopsy can readily identify ATTR amyloid deposition and may identify those at risk of developing cardiac ATTR amyloidosis in the future, permitting earlier intervention with novel therapeutics aimed at preventing accumulation of amyloid. This ongoing study aims to identify the UK prevalence of ATTR amyloid in those with carpal tunnel syndrome and to create a cohort of those who may develop systemic ATTR amyloidosis to further elucidate the disease natural history. Results: In all devices, enough representative synovial tissue was obtained and the instruments were all well visualized by hrMSUS. Core needle biopsy and the integrated needle system were best visualized due to their horizontally shaped closing mechanism. The core needle obtained a high yield of superficial synovial tissue and was the least invasive procedure. Despite handiness and accuracy were higher in the forceps instruments, overall suitability for hrMSUS-guided synovial biopsy was rated highest for the core biopsy needle.
Conclusions:
Technically, all of the tested devices can be used for hrMSUSguided synovial biopsy. Core needle biopsy seems to be most suitable for this intervention due to a low invasiveness, good visualisation and optimal yield of superficial synovial tissue. Background: The most commonly used ultrasonographic measurements for the diagnosis of CTS are measurement of the median nerve cross-sectional area (m-CSA) at different levels of the carpal tunnel.
1 The cross-sectional area of a nerve may differ according to biometric characteristics such as age, sex, height, weight and wrist thickness.
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Objectives: The aim of this study was to assess the diagnostic utility of the ultrasonographic ratio of m-CSA to ulnar nerve cross-sectional area (u-CSA), the m-CSA/ u-CSA ratio, in carpal tunnel syndrome (CTS). Methods: Patients (n=50) with positive symptoms and electromyography results of CTS and control subjects (n=50) with negative electromyography results of CTS were evaluated. The most symptomatic hand of each participant were included in the assesment. Ultrasonographic m-CSA and u-CSA measurements were made at the level of the pisiform bone, and m-CSA/u-CSA ratio was calculated. Results: Using the m-CSA cut-off value of 9.95 mm 2 showed a sensitivity of 92% and a specificity of 42%. Conversely, the cut-off value 13.90 mm 2 showed a sensitivity of 56% and a specificity of 92%. Using the cut-off value 2.96 for the ratio of m-CSA/u-CSA showed a sensitivity of 86% and a specificity of 38% while using the cut-off value 3.71 showed a sensitivity of 52% and a specificity of 90% in the diagnosis of CTS.
Conclusions:
The ratio of m-CSA/u-CSA at the level of the pisiform bone did not provide an additional benefit for the diagnosis of CTS. Ultrasonographic m-CSA measured at the same level was found to be more sensitive and specific method. 
